Top Markets
Coin of the day
Prince Pharmaceutical Co., Ltd. Prince Pharmaceutical Co., Ltd.

Prince Pharmaceutical Co., Ltd.

6935
株式のランク #27308
Prince Pharmaceutical Co., Ltd. operates in the production and global sale of... Prince Pharmaceutical Co., Ltd. operates in the production and global sale of active pharmaceutical ingredients (APIs), primarily focusing on vitamin B1. Its market presence extends across Taiwan, Japan, Korea, and other international territories. The company's product portfolio also encompasses a variety of consumer health items and general medicines. These offerings include popular formulations such as vitamin C tablets and vitamin B complex tablets, alongside specialized supplements like natto and rhodiola extract capsules, probiotic sachets, and various plant extract capsules. In addition to vitamin B1, Prince Pharmaceutical supplies a comprehensive array of other APIs, notably felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. The company's distribution network specifically includes countries within Spain and the wider European continent. Established in 1962, Prince Pharmaceutical Co., Ltd. is based in Yunlin County, Taiwan.
株価
$0.89991249
時価総額
$33.67M
変化(1日)
-0.35%
変化(1年)
7.33%
TW
取引 Prince Pharmaceutical Co., Ltd. (6935)

カテゴリー

Prince Pharmaceutical Co., Ltd.(6935)の収益
Aug 2026 時点の収益 TTM: 0
Prince Pharmaceutical Co., Ltd. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Prince Pharmaceutical Co., Ltd. の収益履歴(2026 ~ 2026)
各年末の収益
収益 変化
提供された日付のデータは十分ではありません。